Liver Cancer: A Comprehensive Guide to Symptoms, Causes, and Treatment
Updated: Nov 11
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 3, 2026
Quick Answer
Liver cancer is a life-threatening cancer that starts in the liver or bile ducts, often resulting from long-term hepatitis B or C infection. Early stages may cause no symptoms, while advanced cases can cause jaundice, abdominal pain and weight loss. [1] Treatment involves surgery, radiation or transplantation, and regular screening is vital for people at high risk.
What the research says
Adding a blood test to ultrasound catches more early liver cancers. Across 32 studies of 13,367 people with cirrhosis, ultrasound alone detected early-stage liver cancer with 47% sensitivity; in studies comparing both approaches, adding the AFP blood test raised early-stage sensitivity to 63%, versus 45% without it. (Tzartzeva et al., Gastroenterology, 2018) [3]
Hepatitis B vaccination at birth sharply reduces liver cancer. In Taiwan's national program, children vaccinated at birth had a much lower risk of liver cancer than unvaccinated birth cohorts (relative risk 0.31). (Chang et al., J Natl Cancer Inst, 2009) [4]
Combination immunotherapy extends survival in advanced liver cancer. In a trial of 336 patients on atezolizumab-bevacizumab and 165 on sorafenib, 67.2% on the combination were alive at 12 months versus 54.6% on sorafenib (hazard ratio for death 0.58). (Finn et al., N Engl J Med, 2020) [5]
What is primary liver cancer?
Primary liver cancer is a life-threatening illness and stands as one of the fastest-growing cancer types in the United States. This malignancy begins directly within the liver tissue or the bile ducts located inside the organ. Because the liver is the body's largest internal organ and performs essential functions for survival, any cancerous growth within it requires immediate and comprehensive medical attention.
There are two distinct categories of liver malignancy: primary and secondary. Primary liver cancer originates within the liver itself, whereas secondary liver cancer involves cells that have spread to the liver from other parts of the body. [1] This guide focuses on primary liver cancer, its variations, and its impact on human health.
Types of Primary Liver Cancer
Primary liver cancer is categorized based on the specific cells where the malignancy begins. The most prevalent form is hepatocellular carcinoma, but other rarer types also exist.
Hepatocellular Carcinoma (HCC): The most common form of primary liver cancer, starting in the main liver cells. It accounts for the majority of cases.
Intrahepatic Cancer (IHC): Also known as bile duct cancer or cholangiocarcinoma, starting in the ducts that carry bile. It accounts for roughly 10% to 20% of cases.
Hepatic Angiosarcoma: A very rare and aggressive cancer beginning in the lining of the liver's blood cells. It accounts for approximately 1% of cases.

What are the symptoms and warning signs of liver cancer?
One of the most challenging aspects of liver cancer is that early stages often produce no noticeable symptoms. [1] As the tumor grows or the disease progresses, physical changes become more apparent. Common symptoms include dark-colored urine, grey or pale stools, and unexplained bruising. Patients may also experience persistent fatigue, fever, and a hard lump or bump on the right side of the body just below the rib cage.
Systemic signs of the disease often involve the digestive system and skin. Many individuals report a loss of appetite, unexplained weight loss, nausea, and vomiting. [1] Upper abdominal pain on the right side or a visibly swollen abdomen are also frequent indicators. Jaundice, characterized by the yellowing of the skin and the whites of the eyes, is a hallmark sign that the liver is struggling to function correctly.
What causes liver cancer, and what are the genetic risk factors?
Liver cancer develops when the DNA of healthy liver cells is damaged or mutated. [1] DNA contains the genetic instructions that regulate how cells grow, multiply, and eventually die. Specifically, mutations can affect oncogenes, which promote cell growth, or tumor suppressor genes, which prevent uncontrolled multiplication. When these genes fail to function correctly, cells grow uncontrollably, forming a malignant tumor. [1]
Common Risk Factors
Several medical conditions and lifestyle factors significantly increase the likelihood of developing liver cancer. The most prominent risk is chronic infection with Hepatitis B (HBV) or Hepatitis C (HCV), both of which can lead to cirrhosis.
Chronic Viral Hepatitis: Long-term HBV or HCV infections are the leading causes of liver cancer globally.
Cirrhosis: Permanent scarring of the liver tissue, often resulting from hepatitis or heavy alcohol consumption. To understand how scarring begins, see our guide to liver fibrosis.
Metabolic Conditions: Obesity, Type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD).
Lifestyle Choices: Heavy alcohol consumption and tobacco use are significant contributors to liver cell damage.
How is liver cancer diagnosed and staged?
Diagnosing liver cancer involves a combination of physical examinations, blood tests, and advanced imaging. Healthcare providers use liver function tests and specific cancer markers in the blood to assess organ health. Imaging technologies such as CT scans, MRIs, and ultrasounds provide detailed pictures of the liver's interior, allowing doctors to identify the size and location of tumors. In some cases, an angiogram or an ERCP test may be necessary to examine blood vessels or bile ducts more closely.
A liver biopsy remains the most reliable method for confirming a diagnosis. During this procedure, a small sample of liver tissue is removed and examined for cancerous cells. Once confirmed, the disease is staged to determine the best course of treatment.
Liver Cancer Staging (BCLC System)
The Barcelona Clinic Liver Cancer (BCLC) system is widely used to stage the disease based on symptoms, liver function, and tumor characteristics.
Stage I (Very Early): Single tumor smaller than 2 cm. No spread; normal bilirubin levels.
Stage II (Early): Single tumor up to 5 cm or multiple tumors under 3 cm. May involve small blood vessels.
Stage III (Intermediate): Multiple tumors or one tumor larger than 5 cm. May involve lymph nodes or large vessels.
Stage IV (Advanced): Tumors of any size. Spread to distant organs like lungs or bones.

How is liver cancer managed and treated?
Treatment for liver cancer is highly personalized, depending on the stage of the disease and the patient's overall health. [2] Options are broadly divided into medical therapies and surgical interventions. Medical treatments include chemotherapy, immunotherapy, and targeted therapy, which aim to kill cancer cells or stop them from growing. [2] Specialized procedures like chemoembolization and radioembolization deliver treatment directly to the tumor through the blood supply.
Surgical options offer the best chance for long-term survival. A hepatectomy involves removing the cancerous portion of the liver, while ablation uses heat or cold to destroy small tumors. For eligible patients, a liver transplant is considered the only definitive cure, as it replaces the diseased organ with a healthy one from a donor. However, the availability of matching donor organs and the patient's ability to undergo major surgery are significant limiting factors.

Conclusion
Liver cancer is a formidable disease that requires early detection and aggressive management. While the diagnosis is life-threatening, advancements in transplantation and targeted therapies are improving outcomes for many patients. Maintaining liver health through vaccination, weight management, and avoiding known toxins like excessive alcohol is the most effective way to reduce long-term risk.
If you have a history of hepatitis, cirrhosis, or other liver-related risk factors, consult a healthcare provider immediately to discuss a personalized screening plan. Early detection is the most critical factor in accessing curative treatment options.
Frequently Asked Questions
What is the difference between primary and secondary liver cancer?
Primary liver cancer starts in the liver tissue itself, while secondary liver cancer refers to cancer that began elsewhere in the body and spread (metastasized) to the liver.
What is the most common type of liver cancer?
Hepatocellular carcinoma (HCC) is the most prevalent form, accounting for the vast majority of primary liver cancer cases.
Can liver cancer be detected early?
Yes, but it is difficult because early-stage liver cancer often produces no symptoms. Screening is recommended for those with known risk factors.
What are the primary risk factors for liver cancer?
The leading risk factors include chronic Hepatitis B or C infections, cirrhosis, heavy alcohol use, obesity, and Type 2 diabetes.
How does hepatitis affect liver cancer risk?
Long-term Hepatitis B and C infections cause chronic inflammation and scarring (cirrhosis), which can eventually lead to DNA mutations in liver cells.
What are the physical symptoms of advanced liver cancer?
Advanced symptoms include jaundice (yellow skin/eyes), a hard lump under the right rib cage, abdominal swelling, and dark-colored urine.
Is liver cancer curable?
Liver cancer can be cured through a successful liver transplant or, in some early cases, through surgical resection (hepatectomy).
What is the Barcelona Clinic Liver Cancer (BCLC) system?
The Barcelona Clinic Liver Cancer (BCLC) system is a staging system that helps doctors plan treatment by evaluating tumor size, the number of tumors, liver function, and the patient's overall symptoms.
How is liver cancer diagnosed?
Diagnosis typically involves a combination of blood tests for liver function and cancer markers, imaging (CT, MRI, ultrasound), and a tissue biopsy.
What surgical options are available for liver cancer?
Surgical options include tumor ablation, hepatectomy (removing part of the liver), and full liver transplantation.
What is a hepatectomy?
A hepatectomy is a surgical procedure where a surgeon removes the portion of the liver that contains the malignant tumor.
Can a liver transplant cure cancer?
Yes, a liver transplant is considered a curative treatment because it removes the entire diseased organ and replaces it with a healthy one.
What are the survival rates for liver cancer?
The overall five-year survival rate is approximately 21%. However, this increases to 37% for early-stage cancer detected before it spreads.
How can I reduce my risk of liver cancer?
Risk reduction involves getting the Hepatitis B vaccine, avoiding Hepatitis C exposure, limiting alcohol, quitting smoking, and maintaining a healthy weight.
Who should be screened for liver cancer?
Regular screening is recommended for individuals with cirrhosis, chronic hepatitis infections, or a combination of diabetes and obesity.
Related Reading
Learn more in our guide to Histotripsy: How Sound Waves Destroy Liver Tumors, Who Qualifies, Risks and Recovery.
Learn more in our guide to Living Donor Liver Transplant: Who Can Donate, Surgery, Risks and Recovery.
Liver Ultrasound: Why It's Done, How to Prepare, Types and What Results Mean explains the no-radiation scan used to check for fatty liver, cirrhosis and liver masses.
Alpha-Fetoprotein (AFP) Test: Pregnancy Screening, Cancer Marker and What Results Mean explains the blood test used in pregnancy screening and as a liver cancer marker.
References
Mayo Clinic Staff. Liver cancer - Symptoms and causes. Mayo Clinic. April 28, 2023. https://www.mayoclinic.org/diseases-conditions/liver-cancer/symptoms-causes/syc-20353659
Mayo Clinic Staff. Liver cancer - Diagnosis and treatment. Mayo Clinic. April 28, 2023. https://www.mayoclinic.org/diseases-conditions/liver-cancer/diagnosis-treatment/drc-20353664
Tzartzeva K, et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology. 2018;154(6):1706-1718.e1. PMID 29425931. https://doi.org/10.1053/j.gastro.2018.01.064
Chang MH, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009;101(19):1348-55. PMID 19759364. https://doi.org/10.1093/jnci/djp288
Finn RS, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382(20):1894-1905. PMID 32402160. https://doi.org/10.1056/NEJMoa1915745
Medical disclaimer
Medical Disclaimer: The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.




Comments